Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer

NCT00265200 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

28

Enrollment

OTHER

Sponsor class

Stopped funding discontinued by sponsor

Conditions

Carcinoma, Non-Small Cell Lung
Carcinoma, Small Cell Lung
Metastases

Interventions

DRUG: zoledronic acid

Sponsor

University of Louisville

Collaborators

[object Object]
[object Object]